Schultz NH, Glosli H, Bjørnsen S, Holme PA(2021) The effect of emicizumab and bypassing agents in patients with hemophilia - An in vitro study Res Pract Thromb Haemost, 5(5), e12561 DOI 10.1002/rth2.12561, PubMed 34263107
Måseide RJ, Berntorp E, Nummi V, Lassila R, Tjønnfjord GE, Holme PA(2021) Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation Haemophilia DOI 10.1111/hae.14355, PubMed 34106506
Schultz NH, Fareed J, Holme PA(2021) Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors-An In Vitro Study Clin Appl Thromb Hemost, 27, 10760296211021156 DOI 10.1177/10760296211021156, PubMed 34060371
